Want to see TXMD full AI Analyst Report?
Total Valuation
TherapeuticsMD has a market cap or net worth of $23.96M. The enterprise value is $22.10.
Market Cap$23.96M
Enterprise Value$22.10
Share Statistics
TherapeuticsMD has 11,574,362 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,574,362
Owned by Insiders1.56%
Owned by Institutions21.87%
Financial Efficiency
TherapeuticsMD’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -12.45%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-12.45%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee3.02M
Profits Per Employee-653.00K
Employee Count1
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TherapeuticsMD is ―. TherapeuticsMD’s PEG ratio is 0.45.
PE Ratio―
PS Ratio6.24
PB Ratio0.70
Price to Fair Value0.70
Price to FCF7.78
Price to Operating Cash Flow<0.01
PEG Ratio0.45
Income Statement
In the last 12 months, TherapeuticsMD had revenue of 3.02M and earned -569.00K in profits. Earnings per share was -0.05.
Revenue3.02M
Gross Profit3.02M
Operating Income-4.21M
Pretax Income-653.00K
Net Income-569.00K
EBITDA-3.02M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was 3.12M and capital expenditures 0.00, giving a free cash flow of 3.12M billion.
Operating Cash Flow3.12M
Free Cash Flow3.12M
Free Cash Flow per Share0.27
Dividends & Yields
TherapeuticsMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change81.58%
50-Day Moving Average2.05
200-Day Moving Average2.01
Relative Strength Index (RSI)52.21
Average Volume (3m)310.58K
Important Dates
TherapeuticsMD upcoming earnings date is Nov 17, 2026, Before Open (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 17, 2026
Ex-Dividend Date―
Financial Position
TherapeuticsMD as a current ratio of 3.02, with Debt / Equity ratio of 20.49%
Current Ratio3.02
Quick Ratio3.02
Debt to Market Cap0.00
Net Debt to EBITDA0.46
Interest Coverage Ratio-526.75
Taxes
In the past 12 months, TherapeuticsMD has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
TherapeuticsMD EV to EBITDA ratio is -5.78, with an EV/FCF ratio of 7.21.
EV to Sales5.78
EV to EBITDA-5.78
EV to Free Cash Flow7.21
EV to Operating Cash Flow7.21
Balance Sheet
TherapeuticsMD has $9.19M in cash and marketable securities with $5.56M in debt, giving a net cash position of $3.63M billion.
Cash & Marketable Securities$9.19M
Total Debt$5.56M
Net Cash$3.63M
Net Cash Per Share$0.31
Tangible Book Value Per Share$2.00
Margins
Gross margin is 100.00%, with operating margin of -139.44%, and net profit margin of -18.83%.
Gross Margin100.00%
Operating Margin-139.44%
Pretax Margin-21.61%
Net Profit Margin-18.83%
EBITDA Margin-99.97%
EBIT Margin-139.44%
Analyst Forecast
The average price target for TherapeuticsMD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast27.78%
EPS Growth Forecast52.88%